These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24154604)

  • 21. [Treatment algorithm for pulmonary arterial hypertension].
    Hoeper MM
    Herz; 2005 Jun; 30(4):326-31. PubMed ID: 15965810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dehydroepiandrosterone: A new treatment for vascular remodeling diseases including pulmonary arterial hypertension.
    Dumas de la Roque E; Savineau JP; Bonnet S
    Pharmacol Ther; 2010 May; 126(2):186-99. PubMed ID: 20206649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary arterial hypertension (PAH) in connective tissue diseases.
    Kähler CM; Colleselli D
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii11-3. PubMed ID: 16987822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical and interventional therapies for pulmonary arterial hypertension.
    Olsson JK; Zamanian RT; Feinstein JA; Doyle RL
    Semin Respir Crit Care Med; 2005 Aug; 26(4):417-28. PubMed ID: 16121319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Female gender and pulmonary arterial hypertension: a complex relationship].
    Manes A; Palazzini M; Dardi F; D'Adamo A; Rinaldi A; Galiè N
    G Ital Cardiol (Rome); 2012 Jun; 13(6):448-60. PubMed ID: 22622125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical advances in pulmonary arterial hypertension: the year in review.
    Bartolome SD
    Curr Opin Pulm Med; 2013 Sep; 19(5):430-6. PubMed ID: 23907455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
    Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
    Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary arterial hypertension: pharmacologic therapies and potential pulmonary artery denervation treatment.
    Zhang YJ; Li MH; Chen SL
    EuroIntervention; 2013 May; 9 Suppl R():R149-54. PubMed ID: 23732148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry.
    Rose ML; Strange G; King I; Arnup S; Vidmar S; O'Donnell C; Kermeen F; Grigg L; Weintraub RG; Celermajer DS
    Intern Med J; 2012 Aug; 42(8):874-9. PubMed ID: 22212153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pregnancy in pulmonary arterial hypertension patients].
    Rosengarten D; Kramer MR
    Harefuah; 2013 Sep; 152(9):547-51, 563, 562. PubMed ID: 24364097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.
    Galiè N; Seeger W; Naeije R; Simonneau G; Rubin LJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):81S-88S. PubMed ID: 15194183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pulmonary arterial hypertension in adult patients with congenital heart disease].
    Serino G; Giacomazzi F
    Pediatr Med Chir; 2010; 32(6):274-9. PubMed ID: 21462449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of pulmonary arterial hypertension with a focus on combination therapies.
    Benza RL; Park MH; Keogh A; Girgis RE
    J Heart Lung Transplant; 2007 May; 26(5):437-46. PubMed ID: 17449411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacological treatment of pulmonary arterial hypertension.
    Frumkin LR
    Pharmacol Rev; 2012 Jul; 64(3):583-620. PubMed ID: 22659328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation].
    Kaemmerer H; Gorenflo M; Hoeper M; Huscher D; Ewert P; Pittrow D
    Dtsch Med Wochenschr; 2013 Jun; 138(23):1247-52. PubMed ID: 23720182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Animal models related to congenital heart disease and clinical research in pulmonary hypertension.
    Loukanov T; Geiger R; Agrawal R
    Cardiology; 2010; 116(1):18-25. PubMed ID: 20424448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imatinib mesylate for the treatment of pulmonary arterial hypertension.
    ten Freyhaus H; Dumitrescu D; Berghausen E; Vantler M; Caglayan E; Rosenkranz S
    Expert Opin Investig Drugs; 2012 Jan; 21(1):119-34. PubMed ID: 22074410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined effects of the ATP-sensitive potassium channel opener pinacidil and simvastatin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
    Jiang L; Zhou T; Liu H
    Pharmazie; 2012 Jun; 67(6):547-52. PubMed ID: 22822545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WHO Group 1 pulmonary arterial hypertension: current and investigative therapies.
    Ventetuolo CE; Klinger JR
    Prog Cardiovasc Dis; 2012; 55(2):89-103. PubMed ID: 23009906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.